Cris Loiren Rodriguez

Array ( [id] => 6353165 [patent_doc_number] => 20100086538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Antibody Molecules Which Bind to Human IL-17' [patent_app_type] => utility [patent_app_number] => 12/306251 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13159 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086538.pdf [firstpage_image] =>[orig_patent_app_number] => 12306251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676163 [patent_doc_number] => 20080213793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'ANTIBODIES THAT BIND RECEPTOR PROTEIN DESIGNATED 2F1' [patent_app_type] => utility [patent_app_number] => 11/768156 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13258 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213793.pdf [firstpage_image] =>[orig_patent_app_number] => 11768156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669363 [patent_doc_number] => 20080044423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/767208 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48094 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044423.pdf [firstpage_image] =>[orig_patent_app_number] => 11767208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5027960 [patent_doc_number] => 20070269407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'USE OF INTERLEUKIN-19 TO TREAT CERVICAL CANCER' [patent_app_type] => utility [patent_app_number] => 11/765289 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6137 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269407.pdf [firstpage_image] =>[orig_patent_app_number] => 11765289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216797 [patent_doc_number] => 07611705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 11/763812 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7210 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611705.pdf [firstpage_image] =>[orig_patent_app_number] => 11763812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33118 [patent_doc_number] => 07790862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'IL-17 and IL-23 antagonists and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/762738 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74872 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790862.pdf [firstpage_image] =>[orig_patent_app_number] => 11762738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490026 [patent_doc_number] => 20090291097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'IL-17 homologous polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/802794 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 68529 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291097.pdf [firstpage_image] =>[orig_patent_app_number] => 11802794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367706 [patent_doc_number] => 20090305265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PROGNOSIS OF CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/298613 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4652 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305265.pdf [firstpage_image] =>[orig_patent_app_number] => 12298613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 31752 [patent_doc_number] => 07790163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Antibodies that bind both IL-17A and IL-17F and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/741189 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 39831 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790163.pdf [firstpage_image] =>[orig_patent_app_number] => 11741189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210949 [patent_doc_number] => 20070249533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'IL-17A AND IL-17F ANTAGONISTS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/691000 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 70474 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249533.pdf [firstpage_image] =>[orig_patent_app_number] => 11691000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132781 [patent_doc_number] => 07696154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins' [patent_app_type] => utility [patent_app_number] => 11/724737 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 30 [patent_no_of_words] => 30831 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696154.pdf [firstpage_image] =>[orig_patent_app_number] => 11724737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4976834 [patent_doc_number] => 20070218065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/684907 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 38466 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218065.pdf [firstpage_image] =>[orig_patent_app_number] => 11684907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675628 [patent_doc_number] => 20080213257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods for treating IL-18 mediated disorders' [patent_app_type] => utility [patent_app_number] => 11/712654 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13712 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213257.pdf [firstpage_image] =>[orig_patent_app_number] => 11712654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791617 [patent_doc_number] => 20080292590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Soluble Receptors and Methods for Treating Autoimmune or Demyelinating Diseases' [patent_app_type] => utility [patent_app_number] => 12/159421 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 59538 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292590.pdf [firstpage_image] =>[orig_patent_app_number] => 12159421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4851968 [patent_doc_number] => 20080317710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Methods For Treating Autoimmune or Demyelinating Diseases' [patent_app_type] => utility [patent_app_number] => 12/159415 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21741 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317710.pdf [firstpage_image] =>[orig_patent_app_number] => 12159415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113525 [patent_doc_number] => 20070197441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'TRUNCATED IL-17RA SOLUBLE RECEPTOR AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/673914 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38706 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197441.pdf [firstpage_image] =>[orig_patent_app_number] => 11673914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234904 [patent_doc_number] => 20100266608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'IL-17 Antagonistic Antibodies' [patent_app_type] => utility [patent_app_number] => 12/223050 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13215 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266608.pdf [firstpage_image] =>[orig_patent_app_number] => 12223050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122939 [patent_doc_number] => 07704945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'IL-18 receptors' [patent_app_type] => utility [patent_app_number] => 11/699676 [patent_app_country] => US [patent_app_date] => 2007-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12689 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704945.pdf [firstpage_image] =>[orig_patent_app_number] => 11699676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112455 [patent_doc_number] => 20070196370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Type 2 cytokine receptor and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 11/652099 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29851 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196370.pdf [firstpage_image] =>[orig_patent_app_number] => 11652099 [rel_patent_id] =>[rel_patent_doc_number] =>)